Pharma Manufacturers & Providers - HARE - HealthCare Analyst Report Romania

Home PharmaPharma Manufacturers & Providers

01-11-2017
EGA: Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine

24-10-2017
APMGR: APMGR requests the resignation of the Minister of Health and the President of NHIH

25-09-2017
MoH: Announcement of round table, organized to inform Romanian Manufacturers and Marketing Authorization Holders about the steps to be taken to meet the requirements of European Directive 2011/62, also known as the "Falsified Medicines Directive".

08-06-2017
EMVO: Announcement regarding the training video about the Onboarding Partner Portal has now been released.

29-05-2017
MoH Press release: ARPIM (Romanian June 6th (Tuesday), 2:00 PM, MoH - Association of International Medicine Producers) asked for a public debate on the MoH draft Order related to the amendment of MoH 1345/2016 regarding daily reporting of inventories and commercial operations with medicinal products for human use in the National Catalog of the prices of the medicinal products authorized for marketing in Romania by wholesale distribution units of medicines, importers, authorized manufacturers and closed and open circuit pharmacies.

24-11-2016
90 per cent of pharmaceutical industry-led clinical trials now published, says new study issued by the Association of the British Pharmaceutical Industry (ABPI)

18-11-2016
EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2016

18-11-2016
EMA: Modelling and simulation in the development of medicines

18-11-2016
EMA: Revising the guideline on first-in-human clinical trials

27-10-2016
European Commission (EC) Question & Answer document for patients builds trust and understanding on biosimilar medicines across Europe

25-10-2016
EMA: Opening up clinical data on new medicines

18-10-2016
EMA: Use of metformin to treat diabetes now expanded to patients with moderately reduced kidney function

17-10-2016
EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2016

10-10-2016
EMA: New treatment for patients with soft tissue sarcoma

06-10-2016
Medicines for Europe: Generic medicines save European countries 100 billion euro per year

27-09-2016
IQWIG issues opinion on ticagrelor (Brilinta, AstraZeneca) for prevention after myocardial infarction

21-09-2016
EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2016 (corrected)

15-09-2016
MoH: New order for updating Annex 1, Order no. 810/2015

02-09-2016
NMMDA informs with regard to submission of documentation in electronic format

02-09-2016
Roche to reunite with ABPI

21-07-2016
NMMDA informs interested parties regarding medicines manufactured within the American company, Pharmaceutics International Inc.

19-07-2016
EFPIA: The EU - US Transatlantic Trade and Investment Partnership (TTIP)

12-07-2016
EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-8 July 2016

22-06-2016
NMMDA informs Healthcare Professionals with regard to safety issues associated with treatment with Thalidomide Celgene (thalidomide)

06-06-2016
EMA: 2015 annual report, published

« Previous

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 Next »

Advanced Search

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company